The UK government has announced that its policy of not requiring domestic batch testing or certification of medicines imported from the EU/European Economic Area is to be made permanent.
UK consumer healthcare industry association, PAGB, says it welcomes the move, which it has been calling for alongside other pharmaceutical...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?